Dental Biopolymer Composites with Antibiotics, Bisphosphonate, and Hydroxyapatite for Possible Use in Bone Tissue Regeneration

Mihaela Maria Budiul,Gabriela Vlase,Daniel Negru,Dorinel Okolišan,Ionela-Amalia Bradu,Alexandra Tăşală,Alexandru Pahomi,Titus Vlase,Daniela Jumanca,Atena Galuscan,Paula Sfirloaga,Nicoleta Carabă,Roxana Popescu,Anamaria Matichescu

DOI: https://doi.org/10.1155/2024/6614044

2024-01-23

Journal of Chemistry

Abstract:The aim of the present study was to formulate new variants of synthetic and animal-source bone materials coated with different biopolymers, containing antibiotics (ampicillin and oxacillin) and alendronate drugs. Validation consists in establishing mixtures that do not present interactions between components. These materials should act as a drug delivery system alongside the bone base. Natural polymers such as chitosan, alginate, and kappa-carrageenan have been shown to be optimal materials for drug delivery due to their intrinsic biocompatibility. Binary, ternary, and quaternary mixtures between components are analyzed by FT-IR spectroscopy, UV-Vis analysis, thermogravimetry (TGA), and scanning electron microscopy (SEM). The analysis led to the validation of materials suitable for the controlled release of active substances, which have the greatest chance of increasing the speed of bone regeneration, as well as helping in the local administration of antibiotics, which currently must be administered in the form of oral formulations or an injection. According to the FTIR, thermogravimetry, UV-Vis, SEM, and cytotoxicity tests performed in this study, it can be said that it is quite easy to obtain materials that can be used in dental practice that facilitate bone reconstruction through local treatment. At the same time, it was found that both active substances can be incorporated into the material together with Alg and Chit, thus limiting the adverse effects and maximizing the local beneficial effects.

chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop new synthetic and animal - derived bone materials. These materials are coated with different biopolymers and contain antibiotics (ampicillin and ofloxacin) as well as alendronic acid drugs. These materials are designed as drug - delivery systems to be used with the bone matrix to promote bone - tissue regeneration, while facilitating the local administration of antibiotics, thus avoiding the current need for oral or injection administration. Specifically, the research objectives include:

1. **Verify the compatibility of materials**: By creating mixtures that do not exhibit interactions between components, ensure that no adverse reactions occur during the preparation of materials.
2. **Increase the speed of bone regeneration**: By controlling the release of active substances, increase the speed of bone regeneration.
3. **Reduce systemic side effects**: Through local administration, reduce the systemic side effects of antibiotics and other drugs, especially the toxicity to other organs.
4. **Enhance biocompatibility and antibacterial properties**: Utilize the inherent biocompatibility of natural polymers such as chitosan, sodium alginate and κ - carrageenan to design composite materials that can effectively deliver drugs.

To achieve these goals, researchers analyzed the physicochemical properties of binary, ternary and quaternary mixtures, including techniques such as Fourier - transform infrared spectroscopy (FT - IR), ultraviolet - visible spectroscopy (UV - Vis), thermogravimetric analysis (TGA) and scanning electron microscopy (SEM) to verify the stability of materials and the integrity of active ingredients. Ultimately, the research hopes to obtain materials that can be used for bone reconstruction in dental practice, which can promote bone regeneration through local treatment while preventing infection.